1. Home
  2. ELVN vs CTBI Comparison

ELVN vs CTBI Comparison

Compare ELVN & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • CTBI
  • Stock Information
  • Founded
  • ELVN 2016
  • CTBI 1903
  • Country
  • ELVN United States
  • CTBI United States
  • Employees
  • ELVN N/A
  • CTBI N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • CTBI Major Banks
  • Sector
  • ELVN Health Care
  • CTBI Finance
  • Exchange
  • ELVN Nasdaq
  • CTBI Nasdaq
  • Market Cap
  • ELVN 1.2B
  • CTBI 1.0B
  • IPO Year
  • ELVN 2020
  • CTBI N/A
  • Fundamental
  • Price
  • ELVN $20.52
  • CTBI $53.20
  • Analyst Decision
  • ELVN Strong Buy
  • CTBI Buy
  • Analyst Count
  • ELVN 5
  • CTBI 3
  • Target Price
  • ELVN $41.20
  • CTBI $59.00
  • AVG Volume (30 Days)
  • ELVN 399.0K
  • CTBI 67.9K
  • Earning Date
  • ELVN 11-12-2025
  • CTBI 10-15-2025
  • Dividend Yield
  • ELVN N/A
  • CTBI 3.98%
  • EPS Growth
  • ELVN N/A
  • CTBI 17.48
  • EPS
  • ELVN N/A
  • CTBI 5.17
  • Revenue
  • ELVN N/A
  • CTBI $261,447,000.00
  • Revenue This Year
  • ELVN N/A
  • CTBI $20.43
  • Revenue Next Year
  • ELVN $20.05
  • CTBI $4.40
  • P/E Ratio
  • ELVN N/A
  • CTBI $10.31
  • Revenue Growth
  • ELVN N/A
  • CTBI 13.97
  • 52 Week Low
  • ELVN $13.30
  • CTBI $44.60
  • 52 Week High
  • ELVN $29.79
  • CTBI $61.67
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.61
  • CTBI 43.36
  • Support Level
  • ELVN $21.08
  • CTBI $50.65
  • Resistance Level
  • ELVN $22.36
  • CTBI $56.22
  • Average True Range (ATR)
  • ELVN 1.00
  • CTBI 1.40
  • MACD
  • ELVN 0.04
  • CTBI -0.19
  • Stochastic Oscillator
  • ELVN 43.98
  • CTBI 40.27

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: